Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Canada Research Chairs

University of Toronto

$200,000.00

Tissue Engineering and Disease Modelling

FY 2023-24

Summary
Discovering new disease therapies is expensive, time-consuming, and inefficient. Furthermore, it is hard to predict how different people will respond to specific therapies and who will benefit most. This is largely because the current 2-dimensional (2D) cellular models used to test new therapies before they are tested in humans do not accurately predict how the therapy will perform in an individual person. Conversely, artificial tissues are constructed from jelly-like hydrogel materials and collections of cells that are assembled into 3-dimensional (3D) structures that mimic the environment inside a human body. These artificial tissues provide an important advantage over current 2D cell culture models because they can be designed to recreate the environmental signals that program cell behaviour. Hence, cells in artificial tissues behave more similarly to those in a person and therefore enable more accurate predictions of how effective a therapy will be. These tissues have the potential to revolutionize therapy discovery and personalize delivery. To realize this vision, Dr. McGuigan, an internationally recognized leader in designing artificial human tissues, will design, manufacture, and analyze artificial tissues to build accurate models of healthy and diseased tissues to accelerate therapy discovery. Further, she will develop artificial tissues using cells from specific people to allow the identification of the most effective therapy for that specific person. To achieve this, she will develop saleable methods to manufacture, perturb, and analyze artificial tissues constructed from patient materials. A unique aspect of her approach is her use of materials engineering tools to design methods that allow cells to be assembled into 3D structures mimicking the environments in the human body while also enabling easy acquisition of data from the system. This allows her team to obtain novel types of information about cell behaviour in the culture models. Using these platforms, Dr. McGuigan will learn how molecular signals between individual cells and their environment program and control cell function. Understanding the signals that control cell function will provide a basis for manipulating and artificially programming cells to design new types of therapies and to predict how different people will response to different therapies. Ultimately, this research will enable the development of new kinds of treatments that can be personalized for individual patients.
Program
Canada Research Chairs
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
CRC-2022-00216
Name nom
McGuigan, Alison
Department département
Chemical Engineering and Applied Chemistry - University of Toronto
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2023
Competition year année de concours
2022
Award amount
200000
Program id
CRC
Program name en
Canada Research Chairs
Program name fr
Chaires de recherche du Canada
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
9998
Committee name en
Canada Research Chair Selection Committee
Committee name fr
Comité de sélection des Chaires de recherche du Canada
Area of application code
10000
Area of application group en
The socioeconomic objective available
Area of application group fr
L'objectif socioéconomique disponible
Area of application en
The socioeconomic objective available
Area of application fr
L'objectif socioéconomique disponible
Research subject code
10000
Research subject group en
The field of research available
Research subject group fr
The field of research available
Research subject en
Le domaine de recherche disponible
Research subject fr
Le domaine de recherche disponible
Field of research list codes
RDF2070106
Field of research list names en
Artificial tissues engineering
Field of research list names fr
Génie des tissus artificiels
Socioeconomic objective list codes
RDS10701
Socioeconomic objective list names en
Human health procedures and pharmaceutical treatments
Socioeconomic objective list names fr
Interventions et traitements pharmaceutiques ayant trait à la santé humaine
Application title
Tissue Engineering and Disease Modelling
Keyword
tissue modelling; microenvironment; cell function; cellular programming; tissue manufacturing; heterogeneity
Application summary
Discovering new disease therapies is expensive, time-consuming, and inefficient. Furthermore, it is hard to predict how different people will respond to specific therapies and who will benefit most. This is largely because the current 2-dimensional (2D) cellular models used to test new therapies before they are tested in humans do not accurately predict how the therapy will perform in an individual person. Conversely, artificial tissues are constructed from jelly-like hydrogel materials and collections of cells that are assembled into 3-dimensional (3D) structures that mimic the environment inside a human body. These artificial tissues provide an important advantage over current 2D cell culture models because they can be designed to recreate the environmental signals that program cell behaviour. Hence, cells in artificial tissues behave more similarly to those in a person and therefore enable more accurate predictions of how effective a therapy will be. These tissues have the potential to revolutionize therapy discovery and personalize delivery. To realize this vision, Dr. McGuigan, an internationally recognized leader in designing artificial human tissues, will design, manufacture, and analyze artificial tissues to build accurate models of healthy and diseased tissues to accelerate therapy discovery. Further, she will develop artificial tissues using cells from specific people to allow the identification of the most effective therapy for that specific person. To achieve this, she will develop saleable methods to manufacture, perturb, and analyze artificial tissues constructed from patient materials. A unique aspect of her approach is her use of materials engineering tools to design methods that allow cells to be assembled into 3D structures mimicking the environments in the human body while also enabling easy acquisition of data from the system. This allows her team to obtain novel types of information about cell behaviour in the culture models. Using these platforms, Dr. McGuigan will learn how molecular signals between individual cells and their environment program and control cell function. Understanding the signals that control cell function will provide a basis for manipulating and artificially programming cells to design new types of therapies and to predict how different people will response to different therapies. Ultimately, this research will enable the development of new kinds of treatments that can be personalized for individual patients.
University of Toronto - $200,000 Grant (2023-24) | Canada Spends